Circassia Group Plc (CIR):企業の財務・戦略的SWOT分析

◆英語タイトル:Circassia Group Plc (CIR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH135228FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Circassia Group Plc (CIR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Circassia Group Plc (Circassia), formerly Circassia Pharmaceuticals plc develops and manufactures drugs for the treatment of allergy and respiratory diseases such as asthma. The company’s marketed products include Niox used for asthma management. The company offers its products to asthma specialists in the US, the UK, Germany and other countries through its network of partners. Circassia is headquartered in Oxford, England, the UK.

Circassia Group Plc Key Recent Developments

Nov 13,2020: Circassia Group: Board appointment
Nov 10,2020: Circassia Group: Change of registered office
Sep 17,2020: Circassia Group : Interim results for the six months ended 30 June 2020
Jun 16,2020: Circassia Group : Preliminary results for the year ended 31 December 2019
May 01,2020: Circassia Pharmaceuticals: Change of name effective

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Circassia Group Plc – Key Facts
Circassia Group Plc – Key Employees
Circassia Group Plc – Key Employee Biographies
Circassia Group Plc – Major Products and Services
Circassia Group Plc – History
Circassia Group Plc – Company Statement
Circassia Group Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Circassia Group Plc – Business Description
Business Segment: COPD (US AZ collaboration)
Overview
Performance
Business Segment: LungFit PH
Overview
Performance
Business Segment: Niox Segment
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: EU
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The UK
Performance
Geographical Segment: The US
Performance
Circassia Group Plc – SWOT Analysis
SWOT Analysis – Overview
Circassia Group Plc – Strengths
Circassia Group Plc – Weaknesses
Circassia Group Plc – Opportunities
Circassia Group Plc – Threats
Circassia Group Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Circassia Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Circassia Group Plc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Circassia Group Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 13, 2020: Circassia Group: Board appointment
Nov 10, 2020: Circassia Group: Change of registered office
Sep 17, 2020: Circassia Group : Interim results for the six months ended 30 June 2020
Jun 16, 2020: Circassia Group : Preliminary results for the year ended 31 December 2019
May 01, 2020: Circassia Pharmaceuticals: Change of name effective
Feb 28, 2020: Circassia Pharmaceuticals: re Board appointment
Jan 09, 2020: Circassia announces business update
Dec 05, 2019: Circassia announces board changes
Sep 26, 2019: Circassia Pharmaceuticals: Interim results for the six months ended 30 June 2019
Aug 12, 2019: Circassia appoints Industry Veteran Jonathan Emms as Chief Operating Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Circassia Group Plc, Key Facts
Circassia Group Plc, Key Employees
Circassia Group Plc, Key Employee Biographies
Circassia Group Plc, Major Products and Services
Circassia Group Plc, History
Circassia Group Plc, Subsidiaries
Circassia Group Plc, Joint Venture
Circassia Group Plc, Key Competitors
Circassia Group Plc, Ratios based on current share price
Circassia Group Plc, Annual Ratios
Circassia Group Plc, Annual Ratios (Cont...1)
Circassia Group Plc, Interim Ratios
Circassia Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Circassia Group Plc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Circassia Group Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Circassia Group Plc (CIR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Verona Pharma Plc (VRP)-製薬・医療分野:企業M&A・提携分析
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Zeria Pharmaceutical Co Ltd (4559):製薬・医療:M&Aディール及び事業提携情報
    Summary Zeria Pharmaceutical Co Ltd (Zeria), formerly Zeria Yakusho Kenkyusho Co Ltd is a pharmaceutical company that manufactures pharmaceutical and non-pharmaceuticals, veterinary pharmaceuticals, industrial chemicals and reagents. The company imports and exports healthcare products such as cosmet …
  • ESAB Holdings Ltd:企業の戦略・SWOT・財務情報
    ESAB Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary ESAB Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • China Petrochemical Development Corporation (1314):企業の財務・戦略的SWOT分析
    China Petrochemical Development Corporation (1314) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Apex Frozen Foods Limited (APEX):企業の財務・戦略的SWOT分析
    Apex Frozen Foods Limited (APEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Idemitsu Kosan Co Ltd (5019)-エネルギー分野:企業M&A・提携分析
    Summary Idemitsu Kosan Co., Ltd. (Idemitsu) is an integrated energy company that explores, produces, refines, and sells oil and gas, lubricants, and petroleum products. Apart from petroleum products, the company also manufactures agricultural chemicals, agricultural materials, and other chemicals. I …
  • Planmeca Oy:企業の戦略的SWOT分析
    Planmeca Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Walchandnagar Industries Ltd
    Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Worthington Industries Inc:戦略・SWOT・企業財務分析
    Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PT Bank Bukopin Tbk:企業の戦略・SWOT・財務分析
    PT Bank Bukopin Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Bukopin Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Oramed Pharmaceuticals Inc (ORMP)-製薬・医療分野:企業M&A・提携分析
    Summary Oramed Pharmaceuticals Inc (Oramed) engages in the research and development of novel pharmaceutical solutions, comprising an oral insulin capsule for the treatment of individuals with diabetes, and orally ingestible capsules or pills for delivery of other polypeptides. It developed a unique …
  • Jabil Inc (JBL)-エネルギー分野:企業M&A・提携分析
    Summary Jabil Inc (Jabil) is a provider of electronic manufacturing services and solutions. It offers electronics design, production and product management services. Its service portfolio includes component selection, sourcing and procurement, integrated design and engineering, enclosure services an …
  • Arena Pharmaceuticals Inc (ARNA):企業の財務・戦略的SWOT分析
    Arena Pharmaceuticals Inc (ARNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Tecpetrol S.A.:企業の戦略・SWOT・財務分析
    Tecpetrol S.A. - Strategy, SWOT and Corporate Finance Report Summary Tecpetrol S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Citius Pharmaceuticals Inc (CTXR):製薬・医療:M&Aディール及び事業提携情報
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • Respira Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Respira Therapeutics Inc (Respira) is a pharmaceutical development company that develops dry powder inhaler technologies. The company develops Inhaler technologies to enable targeted lung delivery of drugs to treat pulmonary diseases. It develops products used for the treatment of pulmonary …
  • Panasonic Corporation (6752):電力:M&Aディール及び事業提携情報
    Summary Panasonic Corporation (Panasonic) develops, Produces, sells and services a range of electric and electronic products in the areas of consumer electronics, housing, B2B and automotive sectors. Its product portfolio include room air-conditioners, TVs, refrigerators, washing machines, personal- …
  • TBG Diagnostics Ltd (TDL)-医療機器分野:企業M&A・提携分析
    Summary TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is molecular diagnostics company that researches, develops, manufactures and markets molecular diagnostics kits, instruments and services. Its products are used in a wide range of applications such as medical researc …
  • Ssr Mining Inc:企業の戦略・SWOT・財務分析
    Ssr Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Ssr Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Luxembourg Institute of Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Luxembourg Institute of Health (LIH), formerly Centre de Recherche Public de la Sante is a biomedical research organisation that offers pre-clinical and clinical research in the areas of biomedicine and healthcare. The organization offers research under various departments such as infection …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆